Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Goldhirsch

Showing results (251-260 of 753) with videos related to

Pageof 76
Sort By:
Medical and Pediatric Oncology|January 1, 1981
Cis-dichlorodiammineplatinum (II) and VP 16-213 combination chemotherapy for non-small cell lung cancerA Goldhirsch, R A Joss, F Cavalli, et al.
Lancet (London, England)|July 18, 1987
Methotrexate/nitrous-oxide toxic interaction in perioperative chemotherapy for early breast cancerA Goldhirsch, R D Gelber, M N Tattersall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1985
Adjuvant therapy in postmenopausal node-positive breast cancerA Goldhirsch, R D Gelber, F Cavalli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2001
Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast CancerA Goldhirsch, J H Glick, R D Gelber, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1983
A phase I trial of marcellomycin with a weekly dose scheduleR A Joss, S Kaplan, A Goldhirsch, et al.
Investigational New Drugs|January 1, 1984
A phase I trial of cis-diammine-1,1-cyclobutane dicarboxylate platinum II (Carboplatin, CBDCA, JM-8) with a single dose every five week-scheduleR A Joss, S Kaplan, A Goldhirsch, et al.
Targeted Oncology|June 28, 2014
QTc prolongation induced by targeted biotherapies used in clinical practice and under investigation: a comprehensive reviewMarzia Locatelli, Carmen Criscitiello, Angela Esposito, et al.
Drugs|April 8, 1998
Practical considerations in the treatment of hepatocellular carcinomaM Colleoni, R A Audisio, F De Braud, et al.
American Journal of Clinical Oncology|February 1, 1986
Combination of chemotherapy with methotrexate, bleomycin, and cis-platinum, and radiation therapy for locally advanced carcinoma of the cervixA Goldhirsch, R Greiner, A Bleher, et al.
Journal of the American Geriatrics Society|February 13, 2021
Geriatrics and palliative medicine leadership is needed now more than ever: What are the training gaps?Ayla R Pelleg, Gabrielle Schiller, Suzanne L Goldhirsch, et al.
Pageof 76

Showing results (251-260 of 753) with videos related to

Sort By:
Pageof 76
Medical and Pediatric Oncology|January 1, 1981
Cis-dichlorodiammineplatinum (II) and VP 16-213 combination chemotherapy for non-small cell lung cancerA Goldhirsch, R A Joss, F Cavalli, et al.
Lancet (London, England)|July 18, 1987
Methotrexate/nitrous-oxide toxic interaction in perioperative chemotherapy for early breast cancerA Goldhirsch, R D Gelber, M N Tattersall, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1985
Adjuvant therapy in postmenopausal node-positive breast cancerA Goldhirsch, R D Gelber, F Cavalli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 18, 2001
Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast CancerA Goldhirsch, J H Glick, R D Gelber, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1983
A phase I trial of marcellomycin with a weekly dose scheduleR A Joss, S Kaplan, A Goldhirsch, et al.
Investigational New Drugs|January 1, 1984
A phase I trial of cis-diammine-1,1-cyclobutane dicarboxylate platinum II (Carboplatin, CBDCA, JM-8) with a single dose every five week-scheduleR A Joss, S Kaplan, A Goldhirsch, et al.
Targeted Oncology|June 28, 2014
QTc prolongation induced by targeted biotherapies used in clinical practice and under investigation: a comprehensive reviewMarzia Locatelli, Carmen Criscitiello, Angela Esposito, et al.
Drugs|April 8, 1998
Practical considerations in the treatment of hepatocellular carcinomaM Colleoni, R A Audisio, F De Braud, et al.
American Journal of Clinical Oncology|February 1, 1986
Combination of chemotherapy with methotrexate, bleomycin, and cis-platinum, and radiation therapy for locally advanced carcinoma of the cervixA Goldhirsch, R Greiner, A Bleher, et al.
Journal of the American Geriatrics Society|February 13, 2021
Geriatrics and palliative medicine leadership is needed now more than ever: What are the training gaps?Ayla R Pelleg, Gabrielle Schiller, Suzanne L Goldhirsch, et al.
Pageof 76